Literature DB >> 22974864

Kidney transplantation from living donors genetically related or unrelated to the recipients: a single-center analysis.

G Santori1, S Barocci, I Fontana, M Bertocchi, A Tagliamacco, R Biticchi, U Valente, A Nocera.   

Abstract

Living-donor programs have gradually become an attractive strategy to expand the donor pool for kidney transplantation (KT). Grafts from living-related donors (LRD) display superior function and longer survival than those obtained from cadaveric sources. Recent reports have shown that outcomes from living-unrelated donors (LUD) are not worse than those from LRD. In this study, we evaluated 135 procedures using living donors performed in our center between 1987 and 2010 (LRD: n = 111; LUD: n = 24). Among the LRD, most donors were mothers (n = 61; 54.95%), fathers (n = 25; 22.52%), and sisters (n = 16; 14.41%). The LUD included wives (n = 17; 70.83%) and husbands (n = 7; 29.17%). The mean recipient ages for LRD versus LUD were 26.94 ± 13.51 and 50.04 ± 8.86 years, respectively (P < .0001). The recipient female/male distribution was 33/78 (29.73%/70.27%) for the LRD versus 6/18 (25%/75%) for the LUD group (P = .643). The donor age was 48.79 ± 9 years in LRD and 49.25 ± 8.44 years in LUD (P = .696). The donor female/male distribution was 72/39 (64.86%/35.16%) in LRD and 17/7 (70.83%/29.17%) in LUD (P = .576). The follow up was 123.79 ± 87.87 months (range, 0.91-279.93). Overall patient and graft survivals were 94.1% and 67.6%, respectively. There was no significant difference in patient survival after stratifying for donor type (LRD: 93.9%; LUD: 95.8%; P = .961) or in graft survival after stratifying for donor type (LRD: 63.8%; LUD: 87.8%; P = .124). Entering donor type as an independent variable in a univariate Cox regression, we observed no significance for either recipient (P = .961) or graft survival (P = .142). The results of this study suggest that LUD utilization should be encouraged in KT programs.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22974864     DOI: 10.1016/j.transproceed.2012.05.061

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  6 in total

1.  Could living unrelated renal transplantation ameliorate the actual shortage of organs in the Balkan region?

Authors:  I Rambabova-Busljetic; Z Popov; J Masin-Spasovska; A Sikole; Gj Selim; S Dohcev; N Ivanovski
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

2.  Histocompatibility testing for organ transplantation purposes in Albania: a single center experience.

Authors:  Erkena Shyti; Alma Idrizi; Genc Sulcebe
Journal:  Balkan Med J       Date:  2014-06-01       Impact factor: 2.021

3.  Alternative Living Kidney Donation Programs Boost Genetically Unrelated Donation.

Authors:  Rosalie A Poldervaart; Mirjam Laging; Tessa Royaards; Judith A Kal-van Gestel; Madelon van Agteren; Marry de Klerk; Willij Zuidema; Michiel G H Betjes; Joke I Roodnat
Journal:  J Transplant       Date:  2015-09-02

4.  Living related and living unrelated kidney transplantations: A systematic review and meta-analysis.

Authors:  Nasser Simforoosh; Hamidreza Shemshaki; Mohammad Nadjafi-Semnani; Mehdi Sotoudeh
Journal:  World J Transplant       Date:  2017-04-24

5.  Outcomes of spousal versus related donor kidney transplants: A comparative study.

Authors:  T Mittal; R Ramachandran; V Kumar; M Rathi; H S Kohli; V Jha; K L Gupta; M Minz; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2014-01

6.  The association of living donor source with patient and graft survival among kidney transplant recipients in the ERA-EDTA Registry - a retrospective study.

Authors:  Samar Abd ElHafeez; Marlies Noordzij; Anneke Kramer; Samira Bell; Emilie Savoye; José Maria Abad Diez; Torbjörn Lundgren; Anna Varberg Reisaeter; Julia Kerschbaum; Carmen Santiuste de Pablos; Fernanda Ortiz; Frederic Collart; Runolfur Palsson; Mustafa Arici; James G Heaf; Ziad A Massy; Kitty J Jager
Journal:  Transpl Int       Date:  2020-10-26       Impact factor: 3.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.